EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF )

Kaitlyn R Scheunemann iD, Katrina E V Jones iD, Kimberly Young iD, Chongben Zhang, Cody McGrath iD, Kimberly R Love iD, Michala de Linde Henriksen iD

Veterinary Ophthalmology · 2026-11 · 29 (6)

DOI: 10.1111/vop.70280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, online erschienen am 16.10.2026. Verfasst von Kaitlyn R Scheunemann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Clonixin, Anti-Inflammatory Agents, Non-Steroidal, alpha-Macroglobulins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the effect of flunixin meglumine, a systemic non‐steroidal anti‐inflammatory drug (NSAID), on the antiproteases, A2M and A1AT, in equine plasma and PRF.

Methods

A prospective cross‐sectional study. Plasma, solid PRF, and liquid PRF were collected from a control‐group that included healthy horses not treated with NSAIDs within the last 3 months. The NSAID‐group were ophthalmology patients with no systemic inflammatory disease, and all received a full dose of flunixin meglumine (1.1 mg/kg BID PO or IV) for three or more days prior to collection. Samples were collected and prepared using a standardized protocol for plasma and PRF preparation. Concentrations of A2M and A1AT were analyzed with ELISA kits. Statistical analysis with Mann–Whitney U tests and Wilcoxon signed‐rank tests was performed using significance set at p < 0.05.

Results

No significant differences were found between the control‐group ( n = 12) and NSAID‐group ( n = 12) for any of the blood products ( p > 0.05). Plasma had a significantly higher amount of A2M compared to solid and liquid PRF (both p < 0.001). Solid PRF had the highest concentration of A1AT and was significantly higher when compared to liquid PRF ( p < 0.001), but not when compared to plasma ( p = 0.071).

Conclusions

The systemic NSAID, flunixin meglumine, does not appear to significantly alter antiprotease concentrations in equine plasma or PRF. Although PRF should not be used as a replacement for plasma, solid PRF may be a good adjunctive therapy for the treatment of keratomalacia due to its high A1AT concentration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClonixinAnti-Inflammatory Agents, Non-Steroidalalpha-MacroglobulinsAnimalsHorsesCross-Sectional StudiesFemaleProspective StudiesMaleHorse Diseases

Stichwörter der Autor:innen

anticollagenaseskeratomalaciameltingnonsteroidal anti‐inflammatory drugulcerative keratitis

Substanzen

flunixin meglumineClonixinAnti-Inflammatory Agents, Non-Steroidalalpha-Macroglobulins

Autor:innen und Institutionen

  • Department of Clinical Science, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Biobehavioral Laboratory, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • KR Love Quantitative Consulting and Collaboration, Athens, Georgia, USA.

ORCID-Profile: Kaitlyn R Scheunemann, Katrina E V Jones, Kimberly Young, Cody McGrath, Kimberly R Love, Michala de Linde Henriksen

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Scheunemann, K. R., Jones, K. E. V., Young, K., Zhang, C., McGrath, C., Love, K. R., & de Linde Henriksen, M. (2026). The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF ). Veterinary Ophthalmology, 29(6). https://doi.org/10.1111/vop.70280

Vancouver

Scheunemann KR, Jones KEV, Young K, Zhang C, McGrath C, Love KR, et al. The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF ). Veterinary Ophthalmology. 2026;29(6). doi:10.1111/vop.70280

BibTeX
@article{Scheunemann2026,
  author = {Scheunemann, Kaitlyn R and Jones, Katrina E V and Young, Kimberly and Zhang, Chongben and McGrath, Cody and Love, Kimberly R and de Linde Henriksen, Michala},
  title = {The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha‐2‐Macroglobulin ( A2M ) and Alpha‐1‐Antitrypsin ( A1AT ) in Equine Plasma and Platelet‐Rich Fibrin ( PRF )},
  journal = {Veterinary Ophthalmology},
  year = {2026},
  volume = {29},
  number = {6},
  doi = {10.1111/vop.70280}
}
Kostenlos starten →